loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Calcium phosphate dibasic anhydrous? Find Direct Compression used in Calcium phosphate dibasic anhydrous to address drug delivery challenges on PharmaCompass.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    View Presentation

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Calcium phosphate dibasic anhydrous

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 16Gangwal Healthcare

    02 1Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

    03 12BASF

    04 1DFE Pharma

    05 4Microlex e.U

    06 1Prachin Chemical

    07 6Sigachi Industries

    08 2The Dow Chemical Company

    09 3Ulanqab Kema New Material

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : DiCOM-DC® SP204

    Application : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Thickeners and Stabilizers

    Excipient Details : DiCOM-DC SP204 is used as a stabilizer, filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Ingredient(s) : Corn Starch, Pregelatinized, Magnesium Oxide Excipient, Microcrystalline Cellulose, Sodium Starch Glycolate

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : Corn Starch, Pregelatinized, Magnesium Oxide Excipient, Microcrystalline Cellulose, Sodium Starch Glycolate

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders, Thickeners and Stabilizers

    Brand : DICOM-DC® SP204

    Applications : DiCOM-DC SP204 is used as a stabilizer, filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare DiCOM-DC® SP204

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : ProBlend®

    Application : Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Lubricants & Glidants

    Excipient Details : ProBlend (Microcrystalline Cellulose) is used as a filler, binder, glidant, DC & co-processed excipient in tablets, capsules, and MUPS formulations.

    Pharmacopoeia Ref : USP-NF

    Technical Specs : NA

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Lubricants & Glidants

    Brand : PROBLEND®

    Applications : ProBlend (Microcrystalline Cellulose) is used as a filler, binder, glidant, DC & co-processed excipient in tablets, capsules, and MUPS formulations.

    Pharmacopoeia Ref : USP-NF

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare ProBlend®

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : DiCOM-DC® SR300

    Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

    Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

    Brand : DICOM-DC® SR300

    Applications : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare DiCOM-DC® SR300

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    04

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : STARLOSE®

    Application : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

    Excipient Details : STARLOSE is used as a diluent, binder, directly compressible (DC), and co-processed excipient in tablets and capsules.

    Pharmacopoeia Ref : IP/EP/USP-NF/IH

    Technical Specs : NA

    Ingredient(s) : Lactose Monohydrate, Maize Starch

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : Lactose Monohydrate, Maize Starch

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

    Brand : STARLOSE®

    Applications : STARLOSE is used as a diluent, binder, directly compressible (DC), and co-processed excipient in tablets and capsules.

    Pharmacopoeia Ref : IP/EP/USP-NF/IH

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare STARLOSE®

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    05

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : Microlose™ M60 P60

    Application : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

    Excipient Details : Microlose M60 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%

    Ingredient(s) : Lactose Monohydrate, Microcrystalline Cellulose

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : Lactose Monohydrate, Microcrystalline Cellulose

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

    Brand : MICROLOSE™ M60 P60

    Applications : Microlose M60 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%

    Grade : Oral

    arrow
    Gangwal Healthcare Microlose™ M60 P60

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    06

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : DiCOM-DC® PL009 P60

    Application : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

    Excipient Details : DiCOM-DC PL009 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

    Pharmacopoeia Ref : IH

    Technical Specs : NA

    Ingredient(s) : Maize Starch, Microcrystalline Cellulose

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : Maize Starch, Microcrystalline Cellulose

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

    Brand : DICOM-DC® PL009 P60

    Applications : DiCOM-DC PL009 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

    Pharmacopoeia Ref : IH

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare DiCOM-DC® PL009 P60

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    07

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : DiCOM-DC® S604

    Application : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

    Excipient Details : DiCOM-DC S604 is used as a DC co-processed excipient with a combination of various polymers that act as fillers and binders in tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : Polyvinyl Pyrrolidone 97% & 93%

    Ingredient(s) : Calcium Carbonate Excipient, Polyvinyl pyrrolidone

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : Calcium Carbonate Excipient, Polyvinyl pyrrolidone

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

    Brand : DICOM-DC® S604

    Applications : DiCOM-DC S604 is used as a DC co-processed excipient with a combination of various polymers that act as fillers and binders in tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : Polyvinyl Pyrrolidone 97% & 93%

    Grade : Oral

    arrow
    Gangwal DiCOM-DC® S604

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    08

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Booth #8.Q10
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : Lactose DC

    Application : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

    Excipient Details : Lactose DC (Lactose Monohydrate) is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

    Pharmacopoeia Ref : IP, USP

    Technical Specs : NA

    Ingredient(s) : Lactose Monohydrate

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : Lactose Monohydrate

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders

    Brand : LACTOSE DC

    Applications : Lactose DC (Lactose Monohydrate) is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

    Pharmacopoeia Ref : IP, USP

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare Lactose DC

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    09

    Sigachi Industries

    ACECEL

    arrow
    2024 ACI Convention
    Not Confirmed

    10

    DFE Pharma

    PHARMACEL 102

    arrow
    2024 ACI Convention
    Not Confirmed

    DFE Pharma

    Germany
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Pharmacel 102

    Application : Direct Compression

    Excipient Details : Pharmacel® 102 has good flow properties enabling high speed direct compression tableting. It is a ideal choice for direct compression & dry granulation formulations and it also has some lubrication properties for smooth tableting experience.

    Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...

    Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 310 g/l; Particle size- D10- 40 ?m, D50- 90 ?m, D90-180 ?m; Hausner ratio-1,42

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Category : Direct Compression

    Brand : PHARMACEL 102

    Applications : Pharmacel® 102 has good flow properties enabling high speed direct compression tableting. It is a ideal choice for direct compression & dry granulation formulations and it also has some lubrication properties for smooth tableting experience.

    Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., JP, IP

    Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 310 g/l; Particle size- D10- 40 ?m, D50- 90 ?m, D90-180 ?m; Hausner ratio-1,42

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    11

    BASF

    KOLLIDON SR

    arrow
    2024 ACI Convention
    Not Confirmed

    BASF

    Germany
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Grade :

    Brand Name : Kollidon SR

    Application : Controlled & Modified Release, Direct Compression, Granulation

    Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

    Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...

    Technical Specs :

    Ingredient(s) : Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Category : Controlled & Modified Release, Direct Compression, Granulation

    Brand : KOLLIDON SR

    Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

    Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    12

    Prachin Chemical

    PARCROS

    arrow
    2024 ACI Convention
    Not Confirmed

    13

    Sigachi Industries

    HICEL

    arrow
    2024 ACI Convention
    Not Confirmed

    14

    Ulanqab Kema New Material

    POVIDONE

    arrow
    2024 ACI Convention
    Not Confirmed

    Ulanqab Kema New Material

    China
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    Brand Name : Povidone

    Application : Direct Compression, Fillers, Diluents & Binders

    Excipient Details : Povidone excipient is used as a binder in oral solid dosage forms such as effervescent tablets and sustained-release capsules. It is also used in the formation of direct compression granules and tablets.

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Povidone

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Povidone

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Category : Direct Compression, Fillers, Diluents & Binders

    Brand : POVIDONE

    Applications : Povidone excipient is used as a binder in oral solid dosage forms such as effervescent tablets and sustained-release capsules. It is also used in the formation of direct compression granules and tablets.

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    15

    Sigachi Industries

    HICEL HFE

    arrow
    2024 ACI Convention
    Not Confirmed

    Sigachi Industries

    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Orodispersible Tablet

    Grade : Oral

    Brand Name : HiCel HFE

    Application : Direct Compression, Disintegrants & Superdisintegrants

    Excipient Details : HiCel HFE has various advantages such as Improved flow, Superior compactibility, low sensitivity to lubrication, better disintegration properties. It is used in direct compression of chewable tablets, fast dissolving tablets & mouth feel enhance...

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Mannitol, Microcrystalline Cellulose

    Dosage Form : Orodispersible Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Mannitol, Microcrystalline Cellulose

    Dosage Form : Orodispersible Tablet

    Category : Direct Compression, Disintegrants & Superdisintegrants

    Brand : HICEL HFE

    Applications : HiCel HFE has various advantages such as Improved flow, Superior compactibility, low sensitivity to lubrication, better disintegration properties. It is used in direct compression of chewable tablets, fast dissolving tablets & mouth feel enhancement.

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    16

    Anhui Sunhere Pharmaceutical Excipients ...

    POVIDONE

    arrow
    2024 ACI Convention
    Not Confirmed

    17

    The Dow Chemical Company

    METHOCEL™

    arrow
    2024 ACI Convention
    Not Confirmed

    The Dow Chemical Company

    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet, Capsule

    Grade :

    Brand Name : METHOCEL™

    Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules

    Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Hydroxypropyl Methylcellulose

    Dosage Form : Tablet, Capsule

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Hydroxypropyl Methylcellulose

    Dosage Form : Tablet, Capsule

    Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules

    Brand : METHOCEL™

    Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    18

    Sigachi Industries

    HICELLAC

    arrow
    2024 ACI Convention
    Not Confirmed

    Sigachi Industries

    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : HiCellac

    Application : Direct Compression, Granulation

    Excipient Details : HiCellac 100 is used in direct compression, dry granulation & capsule filling, suitable for low dose formulations where API content uniformity is critical. It also provides excellent compaction properties & tablet hardness.

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Lactose Monohydrate, Microcrystalline Cellulose

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Lactose Monohydrate, Microcrystalline Cellulose

    Dosage Form : Tablet

    Category : Direct Compression, Granulation

    Brand : HICELLAC

    Applications : HiCellac 100 is used in direct compression, dry granulation & capsule filling, suitable for low dose formulations where API content uniformity is critical. It also provides excellent compaction properties & tablet hardness.

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    19

    Sigachi Industries

    HICEL SMCC

    arrow
    2024 ACI Convention
    Not Confirmed

    20

    Microlex e.U

    MICROLEX® MCC 101

    arrow
    2024 ACI Convention
    Not Confirmed

    21

    Microlex e.U

    MICROLEX® MCC 102

    arrow
    2024 ACI Convention
    Not Confirmed

    Microlex e.U

    Austria
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Microlex® MCC 102

    Application : Direct Compression

    Excipient Details : The plastic defamation characteristics of  MCC 102 type mean that very hard tablets can be produced at light compaction forces, extending tooling lifetime and solving problems with poorly compressible actives.

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs :

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Category : Direct Compression

    Brand : MICROLEX® MCC 102

    Applications : The plastic defamation characteristics of  MCC 102 type mean that very hard tablets can be produced at light compaction forces, extending tooling lifetime and solving problems with poorly compressible actives.

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    22

    Microlex e.U

    MICROLEX® LCM 80.M

    arrow
    2024 ACI Convention
    Not Confirmed

    Microlex e.U

    Austria
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Microlex® LCM 80.m

    Application : Direct Compression, Granulation

    Excipient Details : Lactose monohydrate is typically used for wet or dry granulation. During wet granulation, liquid binders or adhesives are added to the lactose and active mixture, usually by blending.

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m

    Ingredient(s) : Lactose Monohydrate

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Lactose Monohydrate

    Dosage Form : Tablet

    Category : Direct Compression, Granulation

    Brand : MICROLEX® LCM 80.M

    Applications : Lactose monohydrate is typically used for wet or dry granulation. During wet granulation, liquid binders or adhesives are added to the lactose and active mixture, usually by blending.

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    23

    Microlex e.U

    MICROLEX® LCM 120.S

    arrow
    2024 ACI Convention
    Not Confirmed

    Microlex e.U

    Austria
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Microlex® LCM 120.s

    Application : Direct Compression, Granulation

    Excipient Details : It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Sieved; Also Available as Microlex® LCM 180.s, Microlex® LCM 220.s

    Ingredient(s) : Lactose Monohydrate

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Lactose Monohydrate

    Dosage Form : Tablet

    Category : Direct Compression, Granulation

    Brand : MICROLEX® LCM 120.S

    Applications : It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Sieved; Also Available as Microlex® LCM 180.s, Microlex® LCM 220.s

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    24

    Sigachi Industries

    FILLERLAC

    arrow
    2024 ACI Convention
    Not Confirmed

    25

    BASF

    KOLLIWAX S FINE

    arrow
    2024 ACI Convention
    Not Confirmed

    BASF

    Germany
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Suppository, Tablet

    Grade :

    Brand Name : Kolliwax S Fine

    Application : Direct Compression, Granulation, Lubricants & Glidants

    Excipient Details : Lipophilic lubricant, especially for sensitive acidic APIs. Matrix forming agent in sustained-release dosage forms, emulsifying and solubilizing agent in topical formulations and hardening agent in glycerin suppositories

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Palmitic Acid, Stearic Acid

    Dosage Form : Capsule, Granule / Pellet, Suppository, Tablet

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Palmitic Acid, Stearic Acid

    Dosage Form : Capsule, Granule / Pellet, Suppository, Tablet

    Category : Direct Compression, Granulation, Lubricants & Glidants

    Brand : KOLLIWAX S FINE

    Applications : Lipophilic lubricant, especially for sensitive acidic APIs. Matrix forming agent in sustained-release dosage forms, emulsifying and solubilizing agent in topical formulations and hardening agent in glycerin suppositories

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    26

    BASF

    LUDIPRESS

    arrow
    2024 ACI Convention
    Not Confirmed

    27

    BASF

    LUDIPRESS LCE

    arrow
    2024 ACI Convention
    Not Confirmed